Why I Take Benfotiamine Separately From My B-Complex

My B-complex already contained vitamin B1. Then one form made me question what the label was actually telling me.

Image licensed by Shutterstock

I Was Already Taking Vitamin B1

I was already taking a B-complex.

And I had benefited from it.

A good B-complex is more than a source of vitamin B1. Its other B vitamins support energy metabolism, blood-cell formation, nervous-system function, and many of the chemical reactions that keep the body working normally.

Vitamin B2, or riboflavin, helps the body release energy from food and supports antioxidant enzymes and normal cellular function.

Vitamin B3, or niacin, is used to produce NAD, a molecule involved in energy production, DNA repair, and hundreds of metabolic reactions.

Vitamin B5, or pantothenic acid, is needed to produce coenzyme A, which helps the body metabolize fats, carbohydrates, and proteins.

Vitamin B6 supports amino-acid metabolism, neurotransmitter production, immune function, and the formation of haemoglobin.

Vitamin B7, or biotin, supports enzymes involved in the metabolism of fats, carbohydrates, and amino acids.

Vitamin B9, or folate, is essential for DNA synthesis, cell division, and the production of healthy red blood cells.

Vitamin B12 supports nerve function, DNA production, red-blood-cell formation, and the metabolism of certain fatty acids and amino acids.

I was not disappointed with my B-complex, and I did not stop taking it. It gave me several B vitamins together in one convenient formula, and I believed I was benefiting from the combination.

The problem was more specific.

I have lived with lower-back pain for years because of a herniated disc and nerve compression. Part of that pain is neuropathic. It comes from the irritated nerve, not only from the structure of the disc itself.

Whenever I searched online for information about nerve health, neuropathic pain, and lower-back pain, I repeatedly encountered vitamin B1 and benfotiamine.

Benfotiamine was usually described simply as a form of vitamin B1.

Because my B-complex label already listed vitamin B1, I assumed I was already taking essentially the same thing.

The label clearly listed vitamin B1.

So, as far as I was concerned, B1 was already covered.

What I did not understand at the time was that the words “vitamin B1” did not tell me the whole story. My B-complex contained an ordinary form of thiamine, while the human neuropathy research I was finding involved benfotiamine, a modified form of B1 taken at substantially higher doses.

The ordinary thiamine inside my B-complex had never made a noticeable difference to the nerve-related part of my lower-back pain.

Then I added benfotiamine separately.

Benfotiamine is a modified form of vitamin B1. Unlike the ordinary thiamine commonly used in B-complex supplements, it is absorbed differently and can produce much higher thiamine availability in the body.

Around one month later, I noticed a reduction in the nerve-related part of the lower-back pain I had lived with for years.

The pain did not disappear.

Benfotiamine did not repair my herniated disc.

But the difference was noticeable enough to make me ask a question.

If my B-complex already contained vitamin B1, why did taking benfotiamine separately feel different?

What Vitamin B1 Actually Does

Vitamin B1, also known as thiamine, helps the body convert food into energy. It is also important for normal cell growth and nervous-system function.

Inside the body, thiamine is converted into active forms such as thiamine diphosphate. This compound supports important enzymes involved in glucose metabolism and mitochondrial energy production.

A severe B1 deficiency can affect the nerves, brain, muscles, and cardiovascular system. But deficiency was not the question I was investigating.

I wanted to know whether the form of B1 mattered.

The NIH identifies thiamine hydrochloride and thiamine mononitrate as the two forms most commonly used in supplements.

Not Every Form of B1 Is the Same

The two familiar forms are:

• Thiamine hydrochloride

• Thiamine mononitrate

They are stable, water-soluble, inexpensive, and easy to place inside a multivitamin or B-complex.

Then there is benfotiamine.

Benfotiamine is a synthetic thiamine derivative that is absorbed differently and converted into thiamine inside the body. It does not simply travel unchanged through the mitochondrial membrane.

The body still has to process it.

But human pharmacokinetic research shows that oral benfotiamine can produce substantially greater exposure to thiamine and its active metabolites than ordinary thiamine hydrochloride. One human study directly compared the two forms in healthy adults.

That was the first important distinction.

The label may say vitamin B1.

But the form inside the capsule can change what happens after you swallow it.

The Form I Kept Finding Missing

I started checking B-complex labels.

Most of the formulas I examined contained thiamine hydrochloride or thiamine mononitrate.

Benfotiamine was usually missing.

Even when a formula included a more specialized form of B1, the amount was often much smaller than the doses I kept finding in benfotiamine research and stand-alone products.

That made me curious.

Why would supplement companies use ordinary thiamine in the B-complex, then sell benfotiamine separately?

The answer may partly come down to numbers.

The adult daily requirement for thiamine is only around 1.1 to 1.2 mg. A multivitamin can therefore include the daily value without using much capsule space.

Benfotiamine supplements, however, commonly provide around 150 to 300 mg, and some human trials have tested 300 or 600 mg daily.

But from a formulation perspective, replacing a few milligrams of ordinary thiamine with hundreds of milligrams of benfotiamine would clearly change the size and likely the price of the product.

Benfotiamine Was Not My Only Option

Benfotiamine is not the only alternative form of vitamin B1.

There is also allithiamine, a naturally occurring thiamine compound originally identified in garlic.

TTFD, or thiamine tetrahydrofurfuryl disulfide, is a synthetic derivative related to allithiamine. Japanese researchers began studying allithiamine derivatives decades ago because of their ability to increase thiamine availability. TTFD has its own long history of investigation.

There is also fursultiamine, another thiamine derivative.

So why did I choose benfotiamine?

My main interest was not simply energy.

It was neuropathic pain.

The most directly relevant human evidence I found involved benfotiamine.

A human bioavailability study also compared several thiamine derivatives and found that benfotiamine produced greater thiamine availability than fursultiamine and a thiamine disulfide preparation. That did not prove benfotiamine was universally superior, but it made it more relevant to what I was investigating.

What the Neuropathy Studies Actually Found

The first study that caught my attention was a short randomized trial in people with diabetic polyneuropathy.

After three weeks, the researchers reported a statistically significant improvement in the neuropathy score among participants taking benfotiamine. This was not a study of herniated discs, but it did involve painful nerve symptoms.

A later six-week trial compared 300 mg, 600 mg, and placebo.

The higher dose produced a small improvement in the main neuropathy symptom score in the participants who completed the study as planned. However, the result was less convincing when everyone originally assigned to treatment was included in the analysis. The evidence was encouraging, but it was not overwhelming.

Then I found something even more important.

A newer twelve-month randomized trial reported that benfotiamine was well tolerated, but it did not significantly improve several structural, neurological, and clinical measures of diabetic neuropathy.

Only one symptom score showed a trend toward improvement. The longer trial did not confirm a broad neuropathy benefit.

That mattered to me.

It reminded me that one positive short-term study is not the end of the story.

The evidence for benfotiamine and neuropathic pain is mixed.

But it was still the B1 form with the most directly relevant human research for the question I was asking.

Where My Experience Fits

My lower-back pain is not diabetic neuropathy.

It comes from nerve compression associated with a herniated disc.

Those are different conditions.

I cannot use a diabetic-neuropathy trial to prove why my pain decreased.

I can only describe what happened to me.

The ordinary thiamine in my B-complex had never produced a noticeable change.

After taking benfotiamine separately for about a month, the neuropathic part of my lower-back pain felt lower.

It was not a cure.

It was not permanent relief.

But it was enough for me to continue investigating and to keep benfotiamine in my daily routine.

Why I Take It Separately

I did not decide that every B-complex was useless.

A B-complex is convenient.

It places several B vitamins in one capsule.

But convenience does not always provide the specific form or amount I want.

Benfotiamine became one example.

I chose to take it separately because I wanted a clearly identified form, a meaningful dose, and an ingredient source I could trace.

The dose I chose for my own routine was 200 mg.

That is my personal choice. It is not a universal daily requirement, and it is not proof that everyone needs the same amount.

This experience eventually changed the way I used B vitamins.

Instead of relying entirely on one B-complex formula, I began selecting some B vitamins individually according to the form and dose I wanted to investigate.

My B-complex already contained vitamin B1.

But it did not contain the form and amount I had decided to investigate.

The label told me I was taking B1. It did not tell me I was taking the B1 I was looking for.

This article describes my own experience and the research that shaped my decision. It should not be taken as a recommendation that everyone with neuropathic pain or lower-back pain should use benfotiamine. Anyone in a similar situation should discuss the cause of their pain, the appropriate form and dose, possible interactions, and whether benfotiamine is suitable for them with a qualified healthcare professional.

Studies and Sources

1. National Institutes of Health, Office of Dietary Supplements. Thiamin: Fact Sheet for Health Professionals. 2. Xie F, et al. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared with thiamine hydrochloride. Drug Development and Industrial Pharmacy. 2014. 3. Greb A, et al. Comparative bioavailability of various thiamine derivatives after oral administration. International Journal of Clinical Pharmacology and Therapeutics. 1998. 4. Haupt E, Ledermann H, Köpcke W. Benfotiamine in the treatment of diabetic polyneuropathy: a three-week randomized, controlled pilot study. International Journal of Clinical Pharmacology and Therapeutics. 2005. 5. Stracke H, et al. Benfotiamine in diabetic polyneuropathy: results of a randomized, double-blind, placebo-controlled clinical study. Experimental and Clinical Endocrinology & Diabetes. 2008. 6. Ziegler D, et al. Effects of benfotiamine treatment over 12 months on measures of symptomatic diabetic polyneuropathy. BMJ Open Diabetes Research & Care. 2026. 7. Lonsdale D. Thiamine tetrahydrofurfuryl disulfide: a little-known therapeutic agent. Medical Science Monitor. 2004.